This position will be at Haya Therapeutics' headquarters in Lausanne, Switzerland, or San Diego, CA.
Requests a full-time presence on-site.
Conditions of Employment: Proof of Eligibility to work in Switzerland (Swiss work permit or Swiss / European citizenship) or United States of America (U.S. citizenship or work permit/authorization).
If you think you are a strong fit for this position, please apply today!
To Apply: Please send your CV and Cover Letter to ...@hayatx.com. Please specify the position you are applying for and use the SDIR-HR identifier in your cover letter and email subject line.
The position comes with an excellent compensation and benefits package.
HAYA Therapeutics seeks an accomplished and strategic Senior Director of Human Resources to join our dynamic team. In this pivotal leadership role, you will spearhead the development and execution of HR strategies that fuel our growth and innovation in RNA-targeted therapeutics. You will be key in shaping our organizational culture and fostering a positive, inclusive work environment as we expand our presence in Lausanne, San Diego, and Boston.
Main Responsibilities:
- Strategic HR Leadership:
- Develop and implement comprehensive HR strategies that align with HAYA's business objectives and support our rapid growth trajectory.
- Provide expert HR guidance and counsel to the executive team and managers, acting as a trusted advisor on all people-related matters.
- Oversee HR operations, systems, and processes across our Lausanne and San Diego locations, ensuring efficiency and effectiveness.
- Talent Acquisition & Development:
- Lead full-cycle talent acquisition efforts, attracting and securing top talent in the competitive biotech/pharma landscape.
- Design and implement employee development programs that foster a culture of continuous learning and growth.
- Drive initiatives to enhance employee engagement, retention, and well-being, creating a positive and supportive work environment.
- Develop succession planning and leadership development programs to build a strong pipeline of future leaders.
- Organizational Culture & Employee Relations:
- Foster a positive, inclusive company culture that reflects HAYA's core values and promotes collaboration, innovation, and respect.
- Manage employee relations, including conflict resolution and investigations, ensuring a fair and equitable workplace.
- Compliance & Global HR:
- Ensure compliance with employment laws and regulations across multiple jurisdictions, including the US and Switzerland.
- Leverage experience building global HR infrastructure and operations to support HAYA's international expansion.
Qualifications:
- Education & Experience:
- Master's degree in HR, Business, or a related field preferred.
- 10+ years of progressive HR leadership experience, with a proven track record of success at the director level or equivalent.
- Biotech/pharma industry experience is highly desirable.
- Demonstrated experience in scaling HR functions in high-growth environments.
- Strong knowledge of US and Swiss employment laws and HR best practices.
- Excellent leadership, communication, and interpersonal skills, with the ability to build relationships and influence at all levels.
- Strategic thinker with a hands-on approach to execution and driving results.
- SHRM-SCP, SPHR, or equivalent certification is a plus.
- Experience in executive coaching and leadership development is highly valued.
- Proven ability to manage cross-functional and cross-cultural teams.
The Company:
HAYA Therapeutics SA is a precision therapeutics company focused on discovering and developing innovative genomic medicines for fibrotic diseases and age-related health conditions, including cancer. Our discovery engine targets long non-coding RNAs (lncRNAs) within the dark matter of the human genome to identify novel targets and drug candidates. Our lead therapeutic candidate, HTX-001, is currently progressing through pre-clinical development.
Headquartered in Epalinges, Switzerland, HAYA is a rapidly growing company led by a world-class team and supported by a strong investor consortium.
#J-18808-Ljbffr